Merck to buy biopharmaceutical firm Tilos Therapeutics in £608m deal
Tilos Therapeutics is involved in the development of therapeutics, which targets the latent TGFβ complex to treat cancer, fibrosis and autoimmune diseases. TGFβ is a potent cytokine supposed